-
2
-
-
0027333423
-
Role of the major heat shock proteins as molecular chaperones
-
Georgopolis C., Welch W. J. (1993) Role of the major heat shock proteins as molecular chaperones Ann. Rev. Cell Biol. 9, 601–34.
-
(1993)
Ann. Rev. Cell Biol.
, vol.9
, pp. 601-634
-
-
Georgopolis, C.1
Welch, W.J.2
-
3
-
-
0032489016
-
The Hsp70 and Hsp60 chaperone machines
-
Bukau B., Horwich A. L. (1998) The Hsp70 and Hsp60 chaperone machines Cell 92, 351–66.
-
(1998)
Cell
, vol.92
, pp. 351-366
-
-
Bukau, B.1
Horwich, A.L.2
-
4
-
-
15944373162
-
Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo
-
Tang D., Khaleque A. A., Jones E. R., Theriault J. R., Li C., Wong W. H., Stevenson M. A., et al. (2005) Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 10, 46–58.
-
(2005)
Cell Stress Chaperones
, vol.10
, pp. 46-58
-
-
Tang, D.1
Khaleque, A.A.2
Jones, E.R.3
Theriault, J.R.4
Li, C.5
Wong, W.H.6
Stevenson, M.A.7
-
5
-
-
0037111218
-
Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells
-
Noessner E., Gastpar R., Milani V., Brandl A., Hutzler P. J., Kuppner M. C., Roos M., et al. (2002) Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells J Immunol 169, 5424–32.
-
(2002)
J Immunol
, vol.169
, pp. 5424-5432
-
-
Noessner, E.1
Gastpar, R.2
Milani, V.3
Brandl, A.4
Hutzler, P.J.5
Kuppner, M.C.6
Roos, M.7
-
6
-
-
0035925608
-
Heat shock proteins: The “Swiss Army Knife” vaccines against cancers and infectious agents
-
Srivastava P. K., Amato R. J. (2001) Heat shock proteins: the “Swiss Army Knife” vaccines against cancers and infectious agents Vaccine 19, 2590–7.
-
(2001)
Vaccine
, vol.19
, pp. 2590-2597
-
-
Srivastava, P.K.1
Amato, R.J.2
-
8
-
-
0034671358
-
Heat shock protein expression independently predicts clinical outcome in prostate cancer
-
Cornford P. A., Dodson A. R., Parsons K. F., Desmond A. D., Woolfenden A., Fordham M., Neoptolemos J. P., et al. (2000) Heat shock protein expression independently predicts clinical outcome in prostate cancer Cancer Res 60, 7099–105.
-
(2000)
Cancer Res
, vol.60
, pp. 7099-7105
-
-
Cornford, P.A.1
Dodson, A.R.2
Parsons, K.F.3
Desmond, A.D.4
Woolfenden, A.5
Fordham, M.6
Neoptolemos, J.P.7
-
9
-
-
0034994662
-
The inducible Hsp70 as a marker of tumor immunogenicity
-
Clark P. R., Menoret A. (2001) The inducible Hsp70 as a marker of tumor immunogenicity Cell Stress Chaperones 6, 121–5.
-
(2001)
Cell Stress Chaperones
, vol.6
, pp. 121-125
-
-
Clark, P.R.1
Menoret, A.2
-
10
-
-
0036214288
-
Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses
-
Srivastava P. (2002) Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses Annu Rev Immunol 20, 395–425.
-
(2002)
Annu Rev Immunol
, vol.20
, pp. 395-425
-
-
Srivastava, P.1
-
11
-
-
3042740948
-
Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer
-
Srivastava P. (2003) Hypothesis: controlled necrosis as a tool for immunotherapy of human cancer. Cancer Immun. 3, 4.
-
(2003)
Cancer Immun
, vol.3
, pp. 4
-
-
Srivastava, P.1
-
12
-
-
0034328883
-
Immunotherapy of human cancer: Lessons from mice
-
Srivastava P. K. (2000) Immunotherapy of human cancer: lessons from mice Nat Immunol 1, 363–6.
-
(2000)
Nat Immunol
, vol.1
, pp. 363-366
-
-
Srivastava, P.K.1
-
13
-
-
0037108696
-
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings
-
Belli F., Testori A., Rivoltini L., Maio M., Andreola G., Sertoli M. R., Gallino G., et al. (2002) Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings J Clin Oncol 20, 4169–80.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4169-4180
-
-
Belli, F.1
Testori, A.2
Rivoltini, L.3
Maio, M.4
Andreola, G.5
Sertoli, M.R.6
Gallino, G.7
-
14
-
-
10744233222
-
-
Mazzaferro V., Coppa J., Carrabba M. G., Rivoltini L., Schiavo M., Regalia E., Mariani L., et al. (2003) Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer Clin Cancer Res 9, 3235–45.
-
(2003)
Vaccination with Autologous Tumor-Derived Heat-Shock Protein Gp96 after Liver Resection for Metastatic Colorectal Cancer Clin Cancer Res
, vol.9
, pp. 3235-3245
-
-
Mazzaferro, V.1
Coppa, J.2
Carrabba, M.G.3
Rivoltini, L.4
Schiavo, M.5
Regalia, E.6
Mariani, L.7
-
15
-
-
33745090564
-
Heat shock proteins gp96 as immunogens in cancer patients
-
Parmiani G., De Filippo A., Pilla L., Castelli C., and Rivoltini L. (2006) Heat shock proteins gp96 as immunogens in cancer patients Int J Hyperthermia 22, 223–7.
-
(2006)
Int J Hyperthermia
, vol.22
, pp. 223-227
-
-
Parmiani, G.1
de Filippo, A.2
Pilla, L.3
Castelli, C.4
Rivoltini, L.5
-
16
-
-
33646348754
-
-
Pilla L., Patuzzo R., Rivoltini L., Maio M., Pennacchioli E., Lamaj E., Maurichi A., et al. (2006) A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients Cancer Immunol Immunother 55, 958–68.
-
(2006)
A Phase II Trial of Vaccination with Autologous, Tumor-Derived Heat-Shock Protein Peptide Complexes Gp96, in Combination with GM-CSF and Interferon-Alpha in Metastatic Melanoma Patients Cancer Immunol Immunother
, vol.55
, pp. 958-968
-
-
Pilla, L.1
Patuzzo, R.2
Rivoltini, L.3
Maio, M.4
Pennacchioli, E.5
Lamaj, E.6
Maurichi, A.7
-
17
-
-
39749186213
-
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician’s choice of treatment for stage IV melanoma: The C-100-21 Study Group
-
Testori A., Richards J., Whitman E., Mann G. B., Lutzky J., Camacho L., Parmiani G., et al. (2008) Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician’s choice of treatment for stage IV melanoma: the C-100-21 Study Group J Clin Oncol 26, 955–62.
-
(2008)
J Clin Oncol
, vol.26
, pp. 955-962
-
-
Testori, A.1
Richards, J.2
Whitman, E.3
Mann, G.B.4
Lutzky, J.5
Camacho, L.6
Parmiani, G.7
-
18
-
-
46749085802
-
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: A multicentre, open-label, randomised phase III trial
-
Wood C., Srivastava P., Bukowski R., Lacombe L., Gorelov A. I., Gorelov S., Mulders P., et al. (2008) An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial Lancet 372, 145–54.
-
(2008)
Lancet
, vol.372
, pp. 145-154
-
-
Wood, C.1
Srivastava, P.2
Bukowski, R.3
Lacombe, L.4
Gorelov, A.I.5
Gorelov, S.6
Mulders, P.7
-
19
-
-
33750359212
-
Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells
-
Enomoto Y., Bharti A., Khaleque A. A., Song B., Liu C., Apostolopoulos V., Xing P. X., et al. (2006) Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells J Immunol 177, 5946–55.
-
(2006)
J Immunol
, vol.177
, pp. 5946-5955
-
-
Enomoto, Y.1
Bharti, A.2
Khaleque, A.A.3
Song, B.4
Liu, C.5
Apostolopoulos, V.6
Xing, P.X.7
-
20
-
-
0025735629
-
The dendritic cell system and its role in immunogenicity
-
Steinman R. M. (1991) The dendritic cell system and its role in immunogenicity Annu Rev Immunol 9, 271–96.
-
(1991)
Annu Rev Immunol
, vol.9
, pp. 271-296
-
-
Steinman, R.M.1
-
21
-
-
0035347549
-
Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation
-
Steinman R. M. (2001) Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation Mt Sinai J Med 68, 106–66.
-
(2001)
Mt Sinai J Med
, vol.68
, pp. 106-166
-
-
Steinman, R.M.1
-
22
-
-
0030904482
-
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
-
Gong J., Chen D., Kashiwaba M., and Kufe D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells Nat Med 3, 558–61.
-
(1997)
Nat Med
, vol.3
, pp. 558-561
-
-
Gong, J.1
Chen, D.2
Kashiwaba, M.3
Kufe, D.4
-
23
-
-
0036529823
-
Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
-
Gong J., Koido S., Chen D., Tanaka Y., Huang L., Avigan D., Anderson K., et al. (2002) Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12 Blood 99, 2512–7.
-
(2002)
Blood
, vol.99
, pp. 2512-2517
-
-
Gong, J.1
Koido, S.2
Chen, D.3
Tanaka, Y.4
Huang, L.5
Avigan, D.6
Anderson, K.7
-
24
-
-
0036286494
-
Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity
-
Liu Y., Zhang W., Chan T., Saxena A., and Xiang J. (2002) Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity Leuk Res 26, 757–63.
-
(2002)
Leuk Res
, vol.26
, pp. 757-763
-
-
Liu, Y.1
Zhang, W.2
Chan, T.3
Saxena, A.4
Xiang, J.5
-
25
-
-
0036992163
-
Tumour cell-dendritic cell fusion for cancer immunotherapy: Comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols
-
Lindner M., Schirrmacher V. (2002) Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols Eur J Clin Invest 32, 207–17.
-
(2002)
Eur J Clin Invest
, vol.32
, pp. 207-217
-
-
Lindner, M.1
Schirrmacher, V.2
-
26
-
-
0035210399
-
Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice
-
Homma S., Toda G., Gong J., Kufe D., and Ohno T. (2001) Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice J Gastroenterol 36, 764–71.
-
(2001)
J Gastroenterol
, vol.36
, pp. 764-771
-
-
Homma, S.1
Toda, G.2
Gong, J.3
Kufe, D.4
Ohno, T.5
-
27
-
-
0032781867
-
Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
-
Cao X., Zhang W., Wang J., Zhang M., Huang X., Hamada H., and Chen W. (1999) Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells Immunology 97, 616–25.
-
(1999)
Immunology
, vol.97
, pp. 616-625
-
-
Cao, X.1
Zhang, W.2
Wang, J.3
Zhang, M.4
Huang, X.5
Hamada, H.6
Chen, W.7
-
28
-
-
0032533837
-
Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines
-
Wang J., Saffold S., Cao X., Krauss J., and Chen W. (1998) Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines J Immunol 161, 5516–24.
-
(1998)
J Immunol
, vol.161
, pp. 5516-5524
-
-
Wang, J.1
Saffold, S.2
Cao, X.3
Krauss, J.4
Chen, W.5
-
29
-
-
0036334152
-
Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion
-
Hayashi T., Tanaka H., Tanaka J., Wang R., Averbook B. J., Cohen P. A., and Shu S. (2002) Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion Clin Immunol 104, 14–20.
-
(2002)
Clin Immunol
, vol.104
, pp. 14-20
-
-
Hayashi, T.1
Tanaka, H.2
Tanaka, J.3
Wang, R.4
Averbook, B.J.5
Cohen, P.A.6
Shu, S.7
-
30
-
-
0037442132
-
Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells
-
Xia J., Tanaka Y., Koido S., Liu C., Mukherjee P., Gendler S. J., and Gong J. (2003) Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells J Immunol 170, 1980–6.
-
(2003)
J Immunol
, vol.170
, pp. 1980-1986
-
-
Xia, J.1
Tanaka, Y.2
Koido, S.3
Liu, C.4
Mukherjee, P.5
Gendler, S.J.6
Gong, J.7
-
31
-
-
0037379315
-
Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine
-
Kao J. Y., Gong Y., Chen C. M., Zheng Q. D., and Chen J. J. (2003) Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine J Immunol 170, 3806–11.
-
(2003)
J Immunol
, vol.170
, pp. 3806-3811
-
-
Kao, J.Y.1
Gong, Y.2
Chen, C.M.3
Zheng, Q.D.4
Chen, J.J.5
-
32
-
-
0141705384
-
Immature dendritic cell/ tumor cell fusions induce potent antitumour immunity
-
Takeda A., Homma S., Okamoto T., Kufe D., and Ohno T. (2003) Immature dendritic cell/ tumor cell fusions induce potent antitumour immunity Eur J Clin Invest 33, 897–904.
-
(2003)
Eur J Clin Invest
, vol.33
, pp. 897-904
-
-
Takeda, A.1
Homma, S.2
Okamoto, T.3
Kufe, D.4
Ohno, T.5
-
33
-
-
0037347935
-
Antitumor immunopreven-tive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo
-
Zhang J. K., Li J., Zhang J., Chen H. B., and Chen S. B. (2003) Antitumor immunopreven-tive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo World J Gastroenterol 9, 479–84.
-
(2003)
World J Gastroenterol
, vol.9
, pp. 479-484
-
-
Zhang, J.K.1
Li, J.2
Zhang, J.3
Chen, H.B.4
Chen, S.B.5
-
34
-
-
0035170777
-
Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity
-
Li J., Holmes L. M., Franek K. J., Burgin K. E., Wagner T. E., and Wei Y. (2001) Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity Cancer Immunol Immunother 50, 456–62.
-
(2001)
Cancer Immunol Immunother
, vol.50
, pp. 456-462
-
-
Li, J.1
Holmes, L.M.2
Franek, K.J.3
Burgin, K.E.4
Wagner, T.E.5
Wei, Y.6
-
35
-
-
22844441620
-
Dendritic cell/myeloma hybrid vaccine
-
Xia D., Chan T., and Xiang J. (2005) Dendritic cell/myeloma hybrid vaccine Methods Mol Med 113, 225–33.
-
(2005)
Methods Mol Med
, vol.113
, pp. 225-233
-
-
Xia, D.1
Chan, T.2
Xiang, J.3
-
36
-
-
20244379446
-
Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12
-
Homma S., Kikuchi T., Ishiji N., Ochiai K., Takeyama H., Saotome H., Sagawa Y., et al. (2005) Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12 Eur J Clin Invest 35, 279–86.
-
(2005)
Eur J Clin Invest
, vol.35
, pp. 279-286
-
-
Homma, S.1
Kikuchi, T.2
Ishiji, N.3
Ochiai, K.4
Takeyama, H.5
Saotome, H.6
Sagawa, Y.7
-
37
-
-
25444521270
-
Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer
-
Kao J. Y., Zhang M., Chen C. M., and Chen J. J. (2005) Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer Immunol Lett 101, 154–9.
-
(2005)
Immunol Lett
, vol.101
, pp. 154-159
-
-
Kao, J.Y.1
Zhang, M.2
Chen, C.M.3
Chen, J.J.4
-
38
-
-
2642557198
-
Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-trans-duced, spleen-derived dendritic cells and tumour cells
-
Ogawa F., Iinuma H., and Okinaga K. (2004) Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-trans-duced, spleen-derived dendritic cells and tumour cells Scand J Immunol 59, 432–9.
-
(2004)
Scand J Immunol
, vol.59
, pp. 432-439
-
-
Ogawa, F.1
Iinuma, H.2
Okinaga, K.3
-
39
-
-
0035129816
-
Antitumor Effect of Immunizations With Fusions of Dendritic and Glioma Cells in a Mouse Brain Tumor Model
-
Akasaki Y., Kikuchi T., Homma S., Abe T., Kofe D., and Ohno T. (2001) Antitumor Effect of Immunizations With Fusions of Dendritic and Glioma Cells in a Mouse Brain Tumor Model J Immunother 24, 106–13.
-
(2001)
J Immunother
, vol.24
, pp. 106-113
-
-
Akasaki, Y.1
Kikuchi, T.2
Homma, S.3
Abe, T.4
Kofe, D.5
Ohno, T.6
-
40
-
-
0034100236
-
Human tumour and dendritic cell hybrids generated by electrofusion: Potential for cancer vaccines
-
Scott-Taylor T. H., Pettengell R., Clarke I., Stuhler G., La Barthe M. C., Walden P., and Dalgleish A. G. (2000) Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines Biochim Biophys Acta 1500, 265–79.
-
(2000)
Biochim Biophys Acta
, vol.1500
, pp. 265-279
-
-
Scott-Taylor, T.H.1
Pettengell, R.2
Clarke, I.3
Stuhler, G.4
la Barthe, M.C.5
Walden, P.6
Dalgleish, A.G.7
-
41
-
-
0036877104
-
Therapeutic immune response induced by electrofusion of dendritic and tumor cells
-
Tanaka H., Shimizu K., Hayashi T., and Shu S. (2002) Therapeutic immune response induced by electrofusion of dendritic and tumor cells Cell Immunol 220, 1–12.
-
(2002)
Cell Immunol
, vol.220
, pp. 1-12
-
-
Tanaka, H.1
Shimizu, K.2
Hayashi, T.3
Shu, S.4
-
42
-
-
0037689451
-
Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells
-
Siders W. M., Vergilis K. L., Johnson C., Shields J., and Kaplan J. M. (2003) Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells Mol Ther 7, 498–505.
-
(2003)
Mol Ther
, vol.7
, pp. 498-505
-
-
Siders, W.M.1
Vergilis, K.L.2
Johnson, C.3
Shields, J.4
Kaplan, J.M.5
-
43
-
-
0036036401
-
Cell fusion: An approach to generating constitutively proliferating human tumor antigen-presenting cells
-
Jantscheff P., Spagnoli G., Zajac P., and Rochlitz C. F. (2002) Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells Cancer Immunol Immunother 51, 367–75.
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 367-375
-
-
Jantscheff, P.1
Spagnoli, G.2
Zajac, P.3
Rochlitz, C.F.4
-
44
-
-
0037234653
-
In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids
-
Goddard R. V., Prentice A. G., Copplestone J. A., and Kaminski E. R. (2003) In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids Clin Exp Immunol 131, 82–9.
-
(2003)
Clin Exp Immunol
, vol.131
, pp. 82-89
-
-
Goddard, R.V.1
Prentice, A.G.2
Copplestone, J.A.3
Kaminski, E.R.4
-
45
-
-
0037457018
-
Allogeneic dendritic cells fused with tumor cells: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
-
Marten A., Renoth S., Heinicke T., Albers P., Pauli A., Mey U., Caspari R., et al. (2003) Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma Hum Gene Ther 14, 483–94.
-
(2003)
Hum Gene Ther
, vol.14
, pp. 483-494
-
-
Marten, A.1
Renoth, S.2
Heinicke, T.3
Albers, P.4
Pauli, A.5
Mey, U.6
Caspari, R.7
-
46
-
-
3242666838
-
Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application
-
Trevor K. T., Cover C., Ruiz Y. W., Akporiaye E. T., Hersh E. M., Landais D., Taylor R. R., et al. (2004) Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application Cancer Immunol Immunother 53, 705–14.
-
(2004)
Cancer Immunol Immunother
, vol.53
, pp. 705-714
-
-
Trevor, K.T.1
Cover, C.2
Ruiz, Y.W.3
Akporiaye, E.T.4
Hersh, E.M.5
Landais, D.6
Taylor, R.R.7
-
47
-
-
19944428075
-
Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: Characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells
-
Suzuki T., Fukuhara T., Tanaka M., Nakamura A., Akiyama K., Sakakibara T., Koinuma D., et al. (2005) Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells Clin Cancer Res 11, 58–66.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 58-66
-
-
Suzuki, T.1
Fukuhara, T.2
Tanaka, M.3
Nakamura, A.4
Akiyama, K.5
Sakakibara, T.6
Koinuma, D.7
-
48
-
-
14844337815
-
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: Immunological effects and clinical results
-
Trefzer U., Herberth G., Wohlan K., Milling A., Thiemann M., Sharav T., Sparbier K., et al. (2005) Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results Vaccine 23, 2367–73.
-
(2005)
Vaccine
, vol.23
, pp. 2367-2373
-
-
Trefzer, U.1
Herberth, G.2
Wohlan, K.3
Milling, A.4
Thiemann, M.5
Sharav, T.6
Sparbier, K.7
-
49
-
-
3042600552
-
Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy
-
Shimizu K., Kuriyama H., Kjaergaard J., Lee W., Tanaka H., and Shu S. (2004) Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy J Immunother 27, 265–72.
-
(2004)
J Immunother
, vol.27
, pp. 265-272
-
-
Shimizu, K.1
Kuriyama, H.2
Kjaergaard, J.3
Lee, W.4
Tanaka, H.5
Shu, S.6
-
50
-
-
0141461410
-
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines
-
Phan V., Errington F., Cheong S. C., Kottke T., Gough M., Altmann S., Brandenburger A., et al. (2003) A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines Nat Med 9, 1215–9.
-
(2003)
Nat Med
, vol.9
, pp. 1215-1219
-
-
Phan, V.1
Errington, F.2
Cheong, S.C.3
Kottke, T.4
Gough, M.5
Altmann, S.6
Brandenburger, A.7
-
51
-
-
4644254242
-
Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucle-otides
-
Hiraoka K., Yamamoto S., Otsuru S., Nakai S., Tamai K., Morishita R., Ogihara T., et al. (2004) Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucle-otides J Immunol 173, 4297–307.
-
(2004)
J Immunol
, vol.173
, pp. 4297-4307
-
-
Hiraoka, K.1
Yamamoto, S.2
Otsuru, S.3
Nakai, S.4
Tamai, K.5
Morishita, R.6
Ogihara, T.7
-
52
-
-
7044225938
-
Dendritic cells fused with human cancer cells: Morphology, antigen expression, and T cell stimulation
-
Koido S., Ohana M., Liu C., Nikrui N., Durfee J., Lerner A., and Gong J. (2004) Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation Clin Immunol 113, 261–9.
-
(2004)
Clin Immunol
, vol.113
, pp. 261-269
-
-
Koido, S.1
Ohana, M.2
Liu, C.3
Nikrui, N.4
Durfee, J.5
Lerner, A.6
Gong, J.7
-
53
-
-
0036305621
-
Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: Evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination
-
Galea-Lauri J., Darling D., Mufti G., Harrison P., and Farzaneh F. (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination Cancer Immunol Immunother 51, 299–310.
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 299-310
-
-
Galea-Lauri, J.1
Darling, D.2
Mufti, G.3
Harrison, P.4
Farzaneh, F.5
-
54
-
-
0034254702
-
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
-
Gong J., Nikrui N., Chen D., Koido S., Wu Z., Tanaka Y., Cannistra S., et al. (2000) Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity J Immunol 165, 1705–11.
-
(2000)
J Immunol
, vol.165
, pp. 1705-1711
-
-
Gong, J.1
Nikrui, N.2
Chen, D.3
Koido, S.4
Wu, Z.5
Tanaka, Y.6
Cannistra, S.7
-
55
-
-
0034646220
-
Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
-
Gong J., Avigan D., Chen D., Wu Z., Koido S., Kashiwaba M., and Kufe D. (2000) Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells Proc Natl Acad Sci USA 97, 2715–8.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 2715-2718
-
-
Gong, J.1
Avigan, D.2
Chen, D.3
Wu, Z.4
Koido, S.5
Kashiwaba, M.6
Kufe, D.7
-
56
-
-
27144435570
-
Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use
-
Koido S., Nikrui N., Ohana M., Xia J., Tanaka Y., Liu C., Durfee J. K., et al. (2005) Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use Gynecol Oncol 99, 462–71.
-
(2005)
Gynecol Oncol
, vol.99
, pp. 462-471
-
-
Koido, S.1
Nikrui, N.2
Ohana, M.3
Xia, J.4
Tanaka, Y.5
Liu, C.6
Durfee, J.K.7
|